Explore the WHONET Webinar Series focusing on Macros and Quick Analysis Reports by John Stelling, MD, MPH. Learn about data analysis, creating, using, and editing macros, standard and user-defined reports, and WHONET Automation Tool. Discover the future webinar topics and how WHONET macros can strea

6 views • 22 slides

California Department of Education held a webinar to introduce the 2023 Mathematics Framework for Public Schools. Key points covered include core ideas, guidance for instructional planning, chapters overview, and the purpose of the webinar. The framework emphasizes effective and equitable math instr

0 views • 45 slides

Clinical guidelines provide evidence-based recommendations for treating and curing chronic HCV infection in adults to improve treatment rates, reduce morbidity and mortality, and support the New York State Hepatitis C Elimination Plan. Recommendations include considerations in HCV treatment initiati

0 views • 28 slides

Today's webinar covers topics such as 2023 reconciliation, 2024 funding projections, PIC data cleanup, special purpose voucher updates, and more. Presenters from the US Department of Housing & Urban Development share important information and reminders regarding VMS data submission deadlines, eVMS u

0 views • 17 slides

LiveRx Study aims to evaluate the impact of a collaborative program involving community pharmacies and organizations in treating HCV in Alberta. By leveraging pharmacist-led interventions, the initiative focuses on increasing HCV screening, diagnosis, and linkage to care, ultimately aiming to eradic

2 views • 13 slides

The Centers for Disease Control and Prevention (CDC) shared important updates and announcements during the NNDSS eSHARE January Webinar in 2024. Topics included changes based on CSTE position statements, new NNDSS diseases, conditions, event codes, and more. The webinar covered the Total Message Map

5 views • 37 slides

Conducted annually since 2004, the Community Mental Health Survey Trust Webinar provides insights into mental health services, participation, results usage, and eligibility criteria. The survey's impact on NHS performance, CQC assessments, and service improvement planning is highlighted, emphasizing

0 views • 22 slides

The Housing Choice Voucher (HCV) Homeownership Program helps low-income, first-time homebuyers by providing monthly housing assistance payments. This presentation covers key aspects such as program overview, steps to develop the program, operations, counseling, eligible housing, inspections, financi

0 views • 71 slides

Join the HHS-RADV webinar series for updates on protocols and guidelines for the 2019 benefit year. Learn about session agenda, stakeholder guidelines, Q&A submissions, and technical tips for optimal webinar experience.

0 views • 57 slides

This webinar focuses on best practices in waitlist management for the HCV program. It covers topics such as program updates, waitlist rules, regulations, and best practices from various housing authorities. The content discusses the purpose of the waiting list, opening the waiting list, conducting o

0 views • 33 slides

The UK Climate Resilience Programme is hosting a webinar series featuring prominent speakers discussing key topics related to climate change adaptation, impacts, and decision-making options. Presentations and Q&A sessions will cover insights from the IPCC WGII report, projected risks associated with

1 views • 10 slides

April 20, 2023, marks the date for the Society of Thoracic Surgeons' upcoming webinar focusing on Intermacs/Pedimacs data reporting, updates, and processes. The webinar covers important topics such as telehealth visits, quality of life surveys, data utilization, and contact information for database

1 views • 14 slides

Delve into the comprehensive guidelines for both presenters and event promotion for the UN-REDD webinar series. Learn how to define the purpose of your webinar, plan and promote the event effectively, and engage the audience skillfully. Discover essential tips on developing presentations, preparing

0 views • 12 slides

This content provides detailed information about an Initial Teacher Certification Webinar hosted by the Office of Certification and Professional Preparation on April 25, 2018. It covers various topics including certification applications, renewal procedures, adding endorsements, TeachWV.com resource

0 views • 34 slides

Providing details about an upcoming student services webinar, including the agenda covering staff updates, contact information, district updates, communications, and training reminders. The webinar features presentations from various specialists in areas such as ProgressBook Suite support, EMIS supp

1 views • 16 slides

Oregon Health Authority (OHA) hosted a webinar on Measure 110, focusing on Behavioral Health Resource Networks (BHRNs) and grant proposals. The webinar featured introductions to OHA staff, details about Measure 110, BHRN structure, Q&A session, and contact information for grant-related queries. Meas

0 views • 39 slides

This webinar series, "The CACFP Halftime: Thirty on Thursdays," provides interactive sessions on utilizing the Nutrition Facts label in the Child and Adult Care Food Program (CACFP). Operators learn how to identify items for reimbursable meals and snacks. To receive a participation certificate, comp

0 views • 4 slides

Learn about the Performers and Programs Database Webinar happening on October 22, 2021. This webinar, presented by Peter Kowalski and introduced by Sharon B. Phillips, offers valuable information about the database's features, including how performers advertise programs, categorization, virtual prog

0 views • 25 slides

Exploring the escalation of sexual and gender-based violence, domestic violence, and violence against children during crises like COVID-19, this webinar provides strategies to prevent and respond effectively. Participants are guided on identifying risks, taking actionable steps, and fostering a safe

0 views • 26 slides

The Fall 2014 Pre-Administration Webinar provides important information regarding the Georgia High School Graduation Test (GHSGT) for the 2014-2015 academic year. It covers test administration dates, new procedures, enrollment counts, reminders, and deadlines. The webinar emphasizes the use of prope

1 views • 55 slides

Explore the latest advancements in the treatment of Hepatitis C virus (HCV) in HIV-infected individuals through a detailed presentation by Dr. Kara W. Chew. Learn about the initial evaluation for HCV, treatment options for different genotypes, management of advanced fibrosis, recommended approaches

0 views • 9 slides

PASAN (Prisoners with HIV/AIDS Support Action Network) in Ontario exclusively works with prisoners and ex-prisoners to provide support, education, and advocacy related to HIV/HCV and harm reduction. They aim to ensure healthcare access and continuity of care for prisoners living with HIV/HCV, combat

0 views • 20 slides

The ENERGY STAR Laboratory Grade R/F Webinar held on October 23, 2013, featured presentations by Bryan Berringer from the U.S. Department of Energy and Christopher Kent from the U.S. Environmental Protection Agency. The webinar covered topics such as DOE validation testing, test data analysis, draft

0 views • 41 slides

The 2022 report on Hepatitis C in England shows a continued decline in the prevalence of chronic HCV infection, with around 81,000 individuals estimated to be affected in 2020. The report also highlights the distribution of infections among individuals with different drug injecting histories. Data f

0 views • 41 slides

Today's webinar covers updates on 2024 funding, income protections, and program resources. Details include new funding timelines, highlights of the 2024 appropriations, combating source of income discrimination, and more. Stay informed and engaged with the latest developments in the HCV program.

0 views • 17 slides

The Canadian Task Force on Preventive Health Care (CTFPHC) released recommendations on Hepatitis C screening for adults in 2017. The guidelines provide an overview of screening methods, key findings, implementation considerations, and conclusions. Those at higher risk for HCV in Canada include indiv

0 views • 38 slides

This monthly webinar for VA Innovation and Research Review System (VAIRRS) provides key updates and information for attendees. Topics covered include housekeeping instructions, upcoming events, important announcements such as COVID-19 research dashboard and VAEDA webinar, and a focus on IRBNet basic

0 views • 49 slides

In the absence of an HCV vaccine, individuals cured of HCV are still at risk of reinfection, particularly among HIV-co-infected populations. This study aims to examine the risk of reinfection within 2 years of achieving sustained virological response in Europe. Regional differences, treatment regime

0 views • 19 slides

The ATTAIN study compared simeprevir and telaprevir in previous non-responders with genotype 1 HCV. The study included 379 patients with simeprevir and 384 with telaprevir, focusing on SVR12 as the primary endpoint. Baseline characteristics, treatment regimens, patient disposition, and virologic out

0 views • 6 slides

Dr. Fred Stephen Sarfo's research on Hepatitis C in Ghana reveals a notable sero-prevalence of the virus across various populations such as blood donors, prisons inmates, and more. The studies show varying HCV antibody frequencies, highlighting the need for continued surveillance and targeted interv

0 views • 25 slides

The California School Finance Authority is hosting a webinar on May 6, 2020, to provide information on the SB740 program, which offers funding to assist charter schools with facility costs. The program aims to support schools demonstrating a need for financial assistance and serving students eligibl

0 views • 23 slides

The C-EDGE.TN Study evaluated the efficacy of grazoprevir/elbasvir treatment in patients with HCV infection, specifically genotype 1, 4, or 6. The study included 316 patients and aimed to achieve SVR12 rates superior to historical standards. The treatment was well-tolerated, with high SVR12 rates ac

0 views • 9 slides

The CORAL-I trial evaluated the safety and efficacy of the 3D regimen (ombitasvir-paritaprevir-ritonavir + dasabuvir) combined with ribavirin for 24 weeks in liver transplant recipients with recurrent HCV genotype 1. The study included treatment-naive individuals after transplantation, with specific

0 views • 8 slides

This study, supervised by Dr. Christina Greenaway, aims to estimate and compare healthcare utilization in Quebec immigrants and non-immigrants diagnosed with chronic Hepatitis C infection. The research seeks to identify predictors of all-cause and liver-related healthcare utilization. With rising he

0 views • 25 slides

The ALLY-3+ Trial investigates the efficacy of daclatasvir, sofosbuvir, and ribavirin in patients with chronic HCV GT-3 and advanced liver disease. This Phase 3 study compared 12 versus 16 weeks of treatment in treatment-naive or experienced individuals. Results showed promising SVR12 rates and favo

0 views • 9 slides

Study on the efficacy of Daclatasvir and Sofosbuvir in treating Hepatitis C Virus (HCV) Genotype 3, involving treatment-naive and treatment-experienced patients. The Phase 3 trial showcased promising results in achieving SVR12, with detailed patient characteristics, drug dosing, and baseline charact

0 views • 10 slides

In the study of therapeutic trials in HIV/HCV coinfection between 2014-2015, notable trials included ION-4 with LDV/SOF treatment for 12 weeks in HCV/HIV co-infection patients, showing high SVR rates in both treatment-naive and experienced patients. Another trial, Ally-2, involved Daclatasvir and So

0 views • 15 slides

This webinar focuses on utilizing administrative fees to improve leasing success in the HCV program. It covers topics such as funding determination, best practices in administrative fee usage, and permissible uses of administrative fee funding. Participants can learn about how administrative fees ar

0 views • 29 slides

This presentation by Dr. Ricardo A. Franco focuses on the challenges faced in managing and treating patients with HIV/Hepatitis C virus coinfection. It discusses the burden of HCV mono-infection and HIV/HCV co-infection, the impact of HIV co-infection on survival in HCV-related cirrhosis, and the ro

0 views • 26 slides

A study on the effectiveness of grazoprevir/elbasvir in treating HCV-infected individuals on opioid replacement therapy. The study aimed to achieve SVR12 with immediate treatment and compared results to deferred treatment. The primary endpoint SVR12 was achieved in a high percentage of patients on i

0 views • 15 slides